Procter & Gamble remains a high-quality consumer staples name with resilient brands, steady cash flow, and a 70-year dividend streak. But modest growth, margin pressure, and a rich valuation keep the stock in Hold territory.
Procter & Gamble (PG) is a solid but not compelling investment right now, earning an overall grade of B- and a Hold. Our fair value is $162, reflecting durable brands and cash flow offset by modest growth, margin pressure, and a valuation that already discounts much of the stability.
Thesis
Investment thesis: Procter & Gamble (PG) remains a high-quality consumer staples business with durable brands, $19.6B of fiscal 2026 operating cash flow, a 70-year record of annual dividend increases, and a portfolio spread across five recurring-demand categories. The investment case is tempered by modest growth, a 15.5% decline in recent earnings growth, weaker fourth-quarter margins, and a 21.2x forward P/E. At a reference share price of $157.66, the stock suits a moderate-risk investor seeking durability and income more than rapid capital appreciation.
Fiscal 2026 showed both sides of the story. Net sales rose 3.0% to $87.0B, core EPS increased 1.0% to $6.89, and 9 of 10 product categories held or grew organic sales. Yet fourth-quarter diluted EPS fell 15.0%, operating margin declined to 18.6% from 20.8%, and management guided fiscal 2027 core EPS to a range of $6.89 to $7.11. The business is stable, but the stock price already reflects much of that stability.
The central positive is execution recovery. P&G reported that global value and volume share trends improved in the second half of fiscal 2026, while e-commerce sales rose 6.0% and reached 20.0% of total sales. The central risk is valuation: a 3.8 PEG ratio paired with 1.5% revenue growth and low-single-digit EPS guidance leaves limited room for operational disappointment.
Company Overview
Procter & Gamble (PG), founded in 1837 and headquartered in Cincinnati, Ohio, sells branded consumer packaged goods worldwide. The company employs approximately 104,000 people and operates in Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
P&G's brand portfolio includes Tide, Ariel, Downy, Gain, Cascade, Dawn, Febreze, Mr. Clean, Swiffer, Pampers, Always, Bounty, Charmin, Pantene, Olay, SK-II, Gillette, Venus, Oral-B, Crest, Vicks, and Pepto-Bismol. These products reach consumers through mass merchants, grocery stores, club stores, pharmacies, specialty retailers, e-commerce platforms, distributors, and direct channels.
▌Common Questions
Frequently asked questions
+Is PG stock a buy right now?
Procter & Gamble is not a Buy right now; it is a Hold with an overall grade of B-. The business is high quality and defensive, but modest growth, weaker margins, and a 21.2x forward P/E leave limited upside from here.
+What is PG's fair value?
PG's fair value is $162. We arrive at that view by weighing its durable brand portfolio, $19.6B of fiscal 2026 operating cash flow, and 70-year dividend growth streak against low-single-digit fiscal 2027 EPS guidance, a 3.8 PEG ratio, and margin pressure in the latest quarter.
+Why is Procter & Gamble only a Hold?
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
Fiscal 2026 sales were concentrated in Fabric & Home Care at 35.0% of revenue, Baby, Feminine & Family Care at 24.0%, Beauty at 19.0%, Health Care at 14.0%, and Grooming at 8.0%. This mix gives PG broad category exposure while keeping the business focused on products with frequent repeat purchases.
Business Segment Deep Dive
Fabric & Home Care is the largest segment and generated $7.4B of fourth-quarter sales, up 1.0%. Pre-tax earnings fell 9.0% to $1.6B, showing how energy, transportation, material, and trade costs can pressure a large, profitable category even when sales remain positive.
Baby, Feminine & Family Care produced $5.0B of fourth-quarter sales, down 1.0%, with pre-tax earnings down 11.0% to $1.1B. The segment faced pressure from a 1.0% volume decline and a 1.0% price decline. Greater China baby care was a bright spot, with double-digit organic sales growth in each of the six quarters described by management.
Beauty generated $4.0B of fourth-quarter sales, up 6.0%, the strongest reported segment sales growth. Pre-tax earnings fell 17.0% to $588M, which points to a meaningful gap between top-line momentum and profit conversion. Pantene's German business delivered 14.0% value sales growth after increasing influencer content fourfold and tripling total reach.
Health Care produced $2.8B of fourth-quarter sales, up 1.0%, while pre-tax earnings declined 8.0% to $449M. Grooming generated $1.7B of sales, up 1.0%, with pre-tax earnings down 10.0% to $414M. These results reinforce the broader pattern: PG is defending revenue better than margins.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Tide remains the clearest example of PG's ability to renew a mature flagship. Management said the company made its largest upgrade in more than two decades to Tide Original Liquid, which represents more than one-fourth of Tide detergent users. After the upgrade, the product moved from declining sales to high-single-digit growth.
Tide Evo provides a more ambitious innovation path. The product concentrates active surfactant ingredients into fibers, uses no plastic packaging or added water, and is protected by more than 50 granted patents. National expansion was described as on track, with full-scale launch support planned for fiscal 2027. This gives PG a route to premiumize laundry while addressing packaging and convenience.
Mr. Clean offers a second example of product-led category expansion. Its new Magic Eraser lasts twice as long, while the shower and tub scrubber targets a cleaning task management described as consumers' most disliked. Since launch, the brand has delivered 18 times its share of bath-cleaning category growth.
SK-II and Vicks show how PG applies local consumer insights. SK-II's facial essence grew organic sales at a double-digit rate for six consecutive quarters, while Vicks became the number-one cough and cold brand in Latin America after mid-teen organic sales growth and more than 1 point of share growth.
Innovation & Competitive Advantage
PG's competitive advantage rests on the combination of brand equity, research capability, retail relationships, and scale. Management describes the model as superiority across product, packaging, brand communication, retail execution, and consumer value. That framework is supported by a portfolio large enough to fund advertising and research while spreading fixed costs across multiple categories.
The company is also applying technology to the existing moat. PG is scaling AI-enabled tools for brand building, integrated data platforms for internal workflows, AI-enabled molecular discovery for research, and Supply Chain 3.0 for demand planning. Management said some discovery-to-execution processes are moving from weeks to hours.
The moat is durable but not automatic. The fiscal 2026 results showed only 5 of 10 product categories held or grew global share for the year, even though aggregate value and volume share exited the year flat. PG must keep investing to prevent private-label products, local brands, and digital-first competitors from narrowing the gap.
Operations & Supply Chain
PG generated $19.6B of operating cash flow and $15.2B of free cash flow in fiscal 2026. Capital expenditures were $4.4B, and the company reported 100.0% adjusted free cash flow productivity. This cash engine gives management room to fund innovation, absorb cost pressure, and return capital.
Productivity is the operating shock absorber. PG delivered $2.8B of pre-tax productivity improvement across cost of goods sold and selling, general, and administrative expenses in fiscal 2026. Fourth-quarter productivity improvement reached 460 basis points, although the result still included a 130-basis-point decline in core operating margin.
For fiscal 2027, management expects capital spending at 4.5% to 5.5% of sales, adjusted free cash flow productivity of 85.0% to 90.0%, more than $10B of dividends, and approximately $5B of share repurchases. The planned $15B cash return is attractive, but the lower cash productivity outlook reflects the cost burden expected early in the year.
Market Analysis
PG operates in large, recurring consumer markets. Market research from Mordor Intelligence estimates the global household care products market at $202.3B in 2026 and $262.5B in 2031, implying approximately 5.3% annual growth. The narrower household cleaners market is estimated at $170.5B in 2026 and $213.8B in 2031.
Category growth is supported by premiumization, hygiene demand, online retail, convenient formats, and product efficacy. Online retail is projected to grow at a 6.3% annual rate through 2031 in the household cleaners market, while PG's own e-commerce sales rose 6.0% and reached 20.0% of company sales.
The market is not uniformly attractive. Store brands represented 51.0% of U.S. household paper products sold in 2024, according to reporting from The Associated Press. That figure illustrates the pricing pressure facing categories where consumers see limited performance differences. PG is better positioned in products such as Tide, Pampers, Oral-B, and Gillette, where efficacy and brand trust carry more weight.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
PG serves households across income levels, but management said consumers continue to prioritize product performance and efficacy over the lowest price point. Management also said consumers remain willing to trade up when innovation creates a meaningful benefit. Tide Original Liquid, Tide Evo, Mr. Clean Magic Eraser, and premium China baby-care products are direct examples of that approach.
The customer relationship is increasingly omnichannel. PG sells through supermarkets, mass merchants, club stores, pharmacies, specialty beauty retailers, social-commerce channels, and direct-to-consumer platforms. E-commerce's 20.0% share of company sales gives PG a larger digital feedback loop, but it also increases the importance of search placement, retailer media, social content, and online reviews.
Regional behavior differs. Greater China organic sales grew 4.0% in fiscal 2026, Latin America grew 6.0%, and North America grew modestly. In the United States, management reported a gap between 2.0% sell-out growth and a 1.0% sell-in decline during the fourth quarter because of retailer inventory movements and promotional timing.
Competitive Landscape
PG competes with different companies by category. Unilever overlaps in home care, beauty, and personal care. Kimberly-Clark is a major competitor in baby, feminine, family care, and household paper. Colgate-Palmolive competes in oral care, personal care, and home care, while Reckitt is prominent in health, hygiene, and cleaning. Henkel is important in laundry and home care.
PG's scale is a meaningful advantage. The company reported $87.0B of fiscal 2026 sales, $19.7B of operating income, and $19.6B of operating cash flow. That financial base supports advertising, manufacturing, retailer programs, and research spending that smaller brands cannot easily match.
The competitive weakness is growth. Fiscal 2026 organic sales increased only 1.0%, and global share was flat exiting the year. PG's response is to improve core products, build premium formats, use retailer partnerships, and shift brand building toward social and digital commerce. The strategy has produced visible wins, but the company has not yet converted those wins into broad profit acceleration.
Macro & Geopolitical Landscape
Management described the fiscal 2027 operating environment as volatile and challenging. The company expects approximately $1.0B of after-tax cost pressure from raw materials, energy, transportation, and premiums linked to the Middle East conflict. It also expects $150M of higher after-tax net interest expense, $150M of lower non-operating income, and a $50M after-tax foreign-exchange headwind.
The combined after-tax earnings headwind is approximately $1.4B, or $0.56 per share, based on management's fiscal 2027 guidance. That estimate assumes an effective Brent crude oil price of $90 per barrel. The cost burden is expected to be concentrated in the first half of fiscal 2027 because some materials were produced when oil prices exceeded $100 per barrel.
PG's geographic reach creates both diversification and exposure. More than 50.0% of annual sales come from outside the United States, while Greater China and Latin America delivered 4.0% and 6.0% organic growth in fiscal 2026. Currency controls, tariffs, trade restrictions, sanctions, and supply-chain disruption remain material risks to that international earnings base.
Balance Sheet Health
▌Premium Members Only
P&G generated $19.6B of fiscal 2026 operating cash flow and carries a balance sheet strong enough to support a 70-year streak of annual dividend increases.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Procter & Gamble (PG) is a strong business in a slower phase of its cycle. The company combines global brands, recurring consumer demand, $15.2B of free cash flow, and a long dividend record with a balance sheet that remains manageable despite $34.4B of debt.
The investment debate rests on the gap between quality and growth. PG's Tide, Pampers, Pantene, Mr. Clean, Vicks, and SK-II initiatives show that innovation can revive mature categories. However, fiscal 2027 guidance still calls for only 1.0% to 3.0% organic sales growth and 0.0% to 3.0% core EPS growth, while higher costs create a $1.4B after-tax earnings headwind.
For a moderate-risk investor, Hold is the balanced conclusion at $157.66. The stock offers resilience and shareholder returns, but a more compelling entry point would provide greater compensation for the slow growth, margin pressure, and geopolitical cost exposure already visible in the fiscal 2027 outlook.
Procter & Gamble earns a Hold because the company is stable, but the stock already prices in much of that quality. Fiscal 2026 sales rose 3.0% and core EPS rose just 1.0%, while fourth-quarter operating margin fell to 18.6%, leaving little room for disappointment.
+What are the biggest risks for PG stock?
The biggest risks are slow growth and valuation compression if execution slips. The report highlights a 15.5% decline in recent earnings growth, a 3.8 PEG ratio, and management guidance that implies only modest fiscal 2027 earnings growth.
+What could drive PG higher from here?
Improving share trends and successful product innovation could support upside. The report notes that global value and volume share trends improved in the second half of fiscal 2026, e-commerce sales rose 6.0% to 20.0% of total sales, and products like Tide Evo and Tide Original Liquid are helping renew mature categories.
▌For Active Investors
Want Reports Like This on Any Stock?
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.